Literature DB >> 7057295

Calcitonin alters behaviour of isolated osteoclasts.

T J Chambers, C J Magnus.   

Abstract

Osteoclasts were incubated on a glass or plastic substrate and the effect of calcitonin (CT) on their behaviour was observed. Before exposure to CT the osteoclasts were actively motile, the cytoplasm advancing behind broad pseudopodial (lamellipodial) processes which showed intense ruffling activity. CT caused cessation of lamellipodial activity within minutes, followed by gradual fragmentation and retraction of lamellipodia. Complete osteoclast quiescence was regularly induced by concentrations of CT above 50 pg/ml, and lesser degrees of quiescence were induced at concentrations down to 10 pg/ml. This quiescent state was reversed on removing CT from the medium, and was abrogated by prior treatment of osteoclasts with trypsin. The quiescent state did not reduce the longevity of the cells in culture, nor did it affect their resistance to removal from glass by trypsin. CT showed no influence on the pseudopodial activity of osteoclasts, peritoneal macrophages or inflammatory giant cells. Osteoclast quiescence seems to be a reversible state induced by the interaction of CT with a trypsin-sensitive CT receptor, present on osteoclasts. The range of concentrations which induce partial osteoclast quiescence are within the physiological range of serum concentrations in man, and this suggests that CT plays a physiological role in the regulation of osteoclasts may help to identify the precursor cell of the osteoclast and may assist investigations into the mechanism of control of osteoclasis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7057295     DOI: 10.1002/path.1711360104

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  88 in total

Review 1.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

2.  Substrate influences rat osteoclast morphology and expression of potassium conductances.

Authors:  S A Arkett; S J Dixon; S M Sims
Journal:  J Physiol       Date:  1992-12       Impact factor: 5.182

3.  Effect of stress on mRNA expression of H+-ATPase in osteoclasts.

Authors:  Zhang Qing Hong; Liu Meng Tao; Liu Li
Journal:  Mol Cell Biochem       Date:  2010-06-12       Impact factor: 3.396

4.  Inhibition of prostaglandin synthesis leads to a change in adherence of mouse osteoclasts from bone to periosteum.

Authors:  M J Marshall; I Holt; M W Davie
Journal:  Calcif Tissue Int       Date:  1996-09       Impact factor: 4.333

Review 5.  Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.

Authors:  G L Plosker; D McTavish
Journal:  Drugs Aging       Date:  1996-05       Impact factor: 3.923

6.  Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function.

Authors:  N A Athanasou; J Quinn
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

7.  A quantitative cytochemical investigation of osteoclasts and multinucleate giant cells.

Authors:  M H Zheng; J M Papadimitriou; G C Nicholson
Journal:  Histochem J       Date:  1991-04

8.  In vitro bone resorption by isolated multinucleated giant cells from giant cell tumour of bone: light and electron microscopic study.

Authors:  J Kanehisa; T Izumo; M Takeuchi; T Yamanaka; T Fujii; H Takeuchi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 9.  Salmon calcitonin: a review of current and future therapeutic indications.

Authors:  C H Chesnut; M Azria; S Silverman; M Engelhardt; M Olson; L Mindeholm
Journal:  Osteoporos Int       Date:  2007-12-11       Impact factor: 4.507

10.  Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone.

Authors:  A M Flanagan; T J Chambers
Journal:  Calcif Tissue Int       Date:  1991-12       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.